Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Jen Liu

Showing results (171-180 of 400) with videos related to

Pageof 40
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2019
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of ParkinsonismTung-Hung Su, Hung-Chih Yang, Tai-Chung Tseng, et al.
Plos One|December 22, 2018
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in TaiwanChen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Hepatology International|July 24, 2015
Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countriesYock Young Dan, John B Wong, Saeed S Hamid, et al.
Journal of Gastroenterology and Hepatology|July 22, 2014
Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: comparison of genotypes B and C at various immune stagesChun-Jen Liu, Ting-Chih Chen, Pei-Jer Chen, et al.
Journal of Hepatology|December 3, 2019
Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antiviralsChen-Hua Liu, Mei-Hsuan Lee, Jou-Wei Lin, et al.
Journal of Gastroenterology and Hepatology|August 29, 2018
Profile and value of FIB-4 in patients with dual chronic hepatitis C and BChun-Jen Liu, Tai-Chung Tseng, Wan-Ting Yang, et al.
Journal of Clinical Microbiology|March 6, 2015
Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotypingChen-Hua Liu, Cheng-Chao Liang, Chun-Jen Liu, et al.
World Journal of Gastroenterology|July 1, 2014
Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular diseaseKuang-Chun Hu, Horng-Yuan Wang, Sung-Chen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 20, 2021
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agentsShang-Chin Huang, Pin-Nan Cheng, Chen-Hua Liu, et al.
Journal of Clinical Medicine|March 11, 2023
Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus InfectionChen-Hua Liu, Yu-Jen Fang, Chun-Jen Liu, et al.
Pageof 40

Showing results (171-180 of 400) with videos related to

Sort By:
Pageof 40
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2019
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of ParkinsonismTung-Hung Su, Hung-Chih Yang, Tai-Chung Tseng, et al.
Plos One|December 22, 2018
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in TaiwanChen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Hepatology International|July 24, 2015
Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countriesYock Young Dan, John B Wong, Saeed S Hamid, et al.
Journal of Gastroenterology and Hepatology|July 22, 2014
Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: comparison of genotypes B and C at various immune stagesChun-Jen Liu, Ting-Chih Chen, Pei-Jer Chen, et al.
Journal of Hepatology|December 3, 2019
Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antiviralsChen-Hua Liu, Mei-Hsuan Lee, Jou-Wei Lin, et al.
Journal of Gastroenterology and Hepatology|August 29, 2018
Profile and value of FIB-4 in patients with dual chronic hepatitis C and BChun-Jen Liu, Tai-Chung Tseng, Wan-Ting Yang, et al.
Journal of Clinical Microbiology|March 6, 2015
Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotypingChen-Hua Liu, Cheng-Chao Liang, Chun-Jen Liu, et al.
World Journal of Gastroenterology|July 1, 2014
Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular diseaseKuang-Chun Hu, Horng-Yuan Wang, Sung-Chen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 20, 2021
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agentsShang-Chin Huang, Pin-Nan Cheng, Chen-Hua Liu, et al.
Journal of Clinical Medicine|March 11, 2023
Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus InfectionChen-Hua Liu, Yu-Jen Fang, Chun-Jen Liu, et al.
Pageof 40